Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

34567891011

TOP NEWS: GSK's Arexvy RSV vaccine approved in Japan for adults 50-59

22nd Nov 2024 08:40

(Alliance News) - GSK PLC said on Friday that Japan's Ministry of Health, Labour & Welfare has approved the expansion of its Arexvy respiratory syncytial virus vaccine to include adults aged 50 to 59 who are at increased risk of severe RSV. Read More

LONDON BRIEFING: GSK approval; Games Workshop trades ahead of forecast

22nd Nov 2024 07:52

(Alliance News) - London's FTSE 100 is called to open higher on Friday, while the pound and euro struggled ahead of a series key purchasing managers' index readings. Read More

GSK hails positive results for linerixibat in treating relentless itch

19th Nov 2024 09:24

(Alliance News) - GSK PLC on Tuesday said that its investigational targeted inhibitor linerixibat demonstrated sound results for a treatment of relentless itch. Read More

LONDON BROKER RATINGS: HSBC says 'buy' recruiters SThree and Hays

18th Nov 2024 09:36

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and Friday: Read More

LONDON BRIEFING: Elementis says CEO Waterman to step down next year

18th Nov 2024 08:00

(Alliance News) - The FTSE 100 was called to open lower on Monday, ahead of trade balance data from the eurozone and comments from Bank of England Governor Andrew Bailey. Read More

LONDON MARKET CLOSE: Stocks struggle as Powell signals slower Fed cuts

15th Nov 2024 16:51

(Alliance News) - Stock prices in London closed lower, while equities in New York opened in the red after Federal Reserve Chair Jerome Powell dashed rate cut hopes overnight. Read More

LONDON MARKET MIDDAY: Stocks turn greener despite "gloomy" government

15th Nov 2024 12:00

(Alliance News) - Stock prices in London were mostly higher at midday on Friday, despite disappointing data including weaker-than-expected gross domestic product growth. Read More

GSK hails survival results in blood cancer patients with Blenrep

14th Nov 2024 08:54

(Alliance News) - GSK PLC on Thursday said its Blenrep drug has shown overall survival benefits in patients with relapsed or refractory multiple myeloma, the third most common type of blood cancer. Read More

LONDON MARKET CLOSE: Stocks slip and pound falls but dollar rides high

12th Nov 2024 17:06

(Alliance News) - London's FTSE 100 resumed its downward path on Tuesday, as a mixed bag of earnings, political uncertainty, and stronger-than-expected wage growth dented the mood. Read More

LONDON BROKER RATINGS: Jefferies cuts Big Yellow, Shore cuts ITV

12th Nov 2024 09:35

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: Citigroup lifts Great Portland Estates to 'buy'

8th Nov 2024 09:39

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

UK dividends calendar - next 7 days

7th Nov 2024 16:24

Read More

DIRECTOR DEALINGS: Drachs ups stake in Metals Exploration as CFO sells

4th Nov 2024 16:16

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced in the past week and not separately reported by Alliance News: Read More

LONDON BROKER RATINGS: Deutsche cuts Smith & Nephew; Shore lifts Asos

1st Nov 2024 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON BROKER RATINGS: HSBC and Bernstein lift Burberry

31st Oct 2024 09:47

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

TOP NEWS: GSK backs guidance despite third-quarter hit from Zantac

30th Oct 2024 09:28

(Alliance News) - GSK PLC on Wednesday backed its full-year guidance following "another quarter of sales and core operating profit growth", despite a third-quarter profit slump driven by legal charges. Read More

LONDON MARKET OPEN: FTSE 100 falters ahead of UK budget as GSK falls

30th Oct 2024 08:53

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of the UK budget announcement later, while GSK hurt the FTSE 100 after a quarter of tepid vaccine sales. Read More

LONDON BRIEFING: GSK, Aston Martin back outlook; Next raises view

30th Oct 2024 07:50

(Alliance News) - Stocks in London are set to open in the red on Wednesday, ahead of the eagerly-anticipated UK government budget announcement and a batch of US data in the afternoon. Read More

GSK inks deal to buy lupus therapy from Chimagen for USD300 million

29th Oct 2024 12:48

(Alliance News) - GSK PLC on Tuesday said that it has signed a deal to buy CMG1A46 from Chimagen Biosciences for USD300 million upfront. Read More

IN BRIEF: GSK says Arexvy vaccine tests show wider potential for RSV

24th Oct 2024 09:22

GSK PLC - London-based pharmaceutical and biotechnology - Tests of Arexvy, GSK's vaccine against respiratory syncytial virus, shows it can protect a wider range of adults. The vaccine already is approved for use in adults aged 60 years and above in more than 50 countries and in adults 50 to 59 in the US and some European countries. New phase IIb and IIIb trials on adults aged 18 to 49 years at risk of RSV show that two doses of Arexvy bring an immune response for adults aged 18 and above that is similar to one dose in adults aged 50 or more, with an acceptable safety profile. Read More

34567891011
FTSE 100 Latest
Value8,774.65
Change-17.15